Viewing Study NCT03755258

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2026-02-24 @ 3:51 AM
Study NCT ID: NCT03755258
Status: UNKNOWN
Last Update Posted: 2018-11-27
First Post: 2018-11-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis
Sponsor: Zhejiang Hisun Pharmaceutical Co. Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Early Rheumatoid Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ginsenoside compound K tablet View
None Rheumatoid Arthritis View
None Phase Ib study View